Literature DB >> 32379277

Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hematologic Oncologist.

Ilana Graetz1, Courtney R Yarbrough1, Xin Hu1, David H Howard1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32379277      PMCID: PMC7206528          DOI: 10.1001/jamaoncol.2020.0804

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).

Authors:  Lewis S Nelson; Jeanmarie Perrone
Journal:  JAMA       Date:  2012-08-01       Impact factor: 56.272

2.  Addressing the Opioid Epidemic in the United States: Lessons From the Department of Veterans Affairs.

Authors:  Walid F Gellad; Chester B Good; David J Shulkin
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

3.  Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates.

Authors:  Deborah Dowell; Kun Zhang; Rita K Noonan; Jason M Hockenberry
Journal:  Health Aff (Millwood)       Date:  2016-10-01       Impact factor: 6.301

4.  States With Prescription Drug Monitoring Mandates Saw A Reduction In Opioids Prescribed To Medicaid Enrollees.

Authors:  Hefei Wen; Bruce R Schackman; Brandon Aden; Yuhua Bao
Journal:  Health Aff (Millwood)       Date:  2017-04-01       Impact factor: 6.301

5.  No Shortcuts to Safer Opioid Prescribing.

Authors:  Deborah Dowell; Tamara Haegerich; Roger Chou
Journal:  N Engl J Med       Date:  2019-04-24       Impact factor: 91.245

6.  Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.

Authors:  R Bernabei; G Gambassi; K Lapane; F Landi; C Gatsonis; R Dunlop; L Lipsitz; K Steel; V Mor
Journal:  JAMA       Date:  1998-06-17       Impact factor: 56.272

  6 in total
  8 in total

1.  The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic.

Authors:  Bradley D Stein; Flora Sheng; Erin A Taylor; Andrew W Dick; Mark Sorbero; Rosalie Liccardo Pacula
Journal:  Drug Alcohol Depend       Date:  2021-12-28       Impact factor: 4.492

2.  Association of prescription drug monitoring program laws with bedridden and missed work days.

Authors:  Martha Wetzel; Courtney R Yarbrough; Silke A von Esenwein; Jason M Hockenberry
Journal:  Health Serv Res       Date:  2021-08-19       Impact factor: 3.402

3.  Approaches to opioid prescribing in cancer survivors: Lessons learned from the general literature.

Authors:  Katie Fitzgerald Jones; Jessica S Merlin
Journal:  Cancer       Date:  2021-10-11       Impact factor: 6.860

4.  Impacts of an Opioid Safety Initiative on US Veterans Undergoing Cancer Treatment.

Authors:  Lucas K Vitzthum; Vinit Nalawade; Paul Riviere; Mallika Marar; Timothy Furnish; Lewei A Lin; Reid Thompson; James D Murphy
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

5.  This Is a Different Patient Population: Opioid Prescribing Challenges for Patients With Cancer-Related Pain.

Authors:  Yael Schenker; Megan Hamm; Hailey W Bulls; Jessica S Merlin; Rachel Wasilko; Alicia Dawdani; Balchandre Kenkre; Shane Belin; Lindsay M Sabik
Journal:  JCO Oncol Pract       Date:  2021-04-13

6.  "Doctor and pharmacy shopping": A fading signal for prescription opioid use monitoring?

Authors:  Chris Delcher; Daniel R Harris; Changwe Park; Gail K Strickler; Jeffery Talbert; Patricia R Freeman
Journal:  Drug Alcohol Depend       Date:  2021-02-15       Impact factor: 4.492

7.  US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life.

Authors:  Andrea C Enzinger; Kaushik Ghosh; Nancy L Keating; David M Cutler; Mary Beth Landrum; Alexi A Wright
Journal:  J Clin Oncol       Date:  2021-07-22       Impact factor: 50.717

8.  National Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United States.

Authors:  Vikram Jairam; Daniel X Yang; Vivek Verma; James B Yu; Henry S Park
Journal:  JAMA Netw Open       Date:  2020-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.